CD4 and psoriasis: Furthermore, CD8+ T cells producing IL-17 and CD4+ T cells producing IL-22 remain in resolved lesions and can be stimulated to produce psoriasis-related cytokines even after treatment with biologics such as infliximab for several years [51].